Cells4Life
Cells4Life is a UK-based private umbilical cord blood and stem cell bank serving expectant parents with collection, processing, and long-term cryogenic storage of cord blood, cord tissue, placenta, and amnion samples across the UK, Europe, USA, and Middle East, holding over 50% of the UK private banking market.
- Company typePrivate
- Founded2002
- HeadquartersBurgess Hill, United Kingdom
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Cells4Life does
Cells4Life is a privately held UK umbilical cord blood and stem cell bank founded in 2002 and headquartered in Burgess Hill, West Sussex. The company collects, processes, tests, and stores newborn stem cells derived from umbilical cord blood, cord tissue, placenta, and amnion for expectant families across the UK, Europe, USA, and the Middle East. Its technology stack combines the industry-standard AXP (AutoXpresser Platform) processing system — the same platform used exclusively by the NHS — with its proprietary TotiCyte technology, which powers the premium Cells*Plus* service and is claimed to retain up to 2.2X more viable haematopoietic stem cells than standard AXP processing, with 90% post-processing yield and 66% post-thaw yield versus 87% and 42% respectively.
The business operates a direct-to-consumer model with tiered subscription pricing. Entry-level cord blood banking starts at £550 plus annual storage fees, with upgrades to Cells*Plus*, cord tissue, placenta, amnion, multiple sample storage, and non-invasive prenatal testing (NIPT) as add-ons. Cells4Life maintains collection partnerships with over 200 NHS and private hospitals across the UK and provides 24/7/365 medical courier service to accommodate all birth types including home births and delayed cord clamping. The company claims to store over 50% of all privately banked cord blood samples in the UK, making it the country's largest family cord blood bank by volume. It is the only UK provider of placenta and amnion cell storage.
Cells4Life operates as Cells4Life Group LLP, a founder-owned limited liability partnership co-founded by Lesley-Ann Martin (Chief Scientific Officer), with no disclosed institutional funding, parent company, or public listing. The company holds a dense stack of regulatory credentials — HTA licence, FCA regulation, AABB accreditation, UK NEQAS accreditation, ISO 9001, and ISO 13485 — that collectively form a substantial compliance moat for new market entrants.
Cells4Life firmographics
Firmographics- Name
- Cells4Life
- Legal name
- Cells4Life Group LLP
- Website
- https://cells4life.com
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Cells4Life is a UK-based private umbilical cord blood and stem cell bank serving expectant parents with collection, processing, and long-term cryogenic storage of cord blood, cord tissue, placenta, and amnion samples across the UK, Europe, USA, and Middle East, holding over 50% of the UK private banking market.
- Ownership category
- akta.pro rank
Cells4Life industry classification
Industry- Product category
- Stem Cell Banking Services
- NAICS
- Blood and Organ Banks (621991)
- SIC
- Services-Medical Laboratories (8071), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)
- akta.pro secondary industries
- Stem Cell–Based Regenerative Therapies (HLAAAGAA), Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ)
Keywords
Where Cells4Life is headquartered
LocationHeadquarters
- HQ city
- Burgess Hill
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Cells4Life business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Revenue model
- Cord Blood Banking - Cells (Standard Service): Standard cord blood stem cell collection, processing, testing, and long-term cryogenic storage using the AXP processing system. Customers pay an upfront fee plus an annual storage fee for ongoing preservation of their baby's cord blood stem cells.
- Cord Blood Banking - Cells*Plus* (Premium Service): Premium upgrade using proprietary TotiCyte technology, retaining up to 2.2X more viable stem cells than the standard Cells service. Higher price point than the Cells tier, reflecting the enhanced processing technology and superior cell yield outcomes.
- Cord Tissue Banking: Collection, processing, and storage of umbilical cord tissue stem cells (Wharton's Jelly mesenchymal stem cells) for future regenerative medicine applications. Sold as a standalone or add-on service to cord blood banking.
- Placenta Banking (Exclusive UK Service): Exclusive UK service for banking placenta-derived stem cells (Amnion and Placental Cells). Sold as a premium add-on to cord blood and/or cord tissue banking packages, leveraging Cells4Life's unique position as the only UK placenta bank.
- Amnion Banking: Banking of amnion placental tissue, which contains powerful regenerative cells. Part of the broader placenta banking service offering.
- Prenatal Testing (NIPT): Non-Invasive Prenatal Testing (NIPT) services offered as an additional service within the Cells4Life product ecosystem, providing expectant parents with prenatal screening options alongside stem cell banking.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Cells (Standard) - AXP processing |
| Subscription | Annual | Cells*Plus* (Premium) - TotiCyte processing |
Go-to-market motion1 record
Distribution channels5 records
Marketing channels6 records
Cells4Life product offering
Product offeringCore offering
Cells4Life collects, processes, tests, and cryogenically stores umbilical cord blood, cord tissue, placenta, and amnion-derived stem cells for expectant parents and families, offering both a standard Cells service (using the AXP system trusted by the NHS) and a premium Cells*Plus* service powered by proprietary TotiCyte technology that retains up to 2.2X more viable stem cells. Services include 24/7 medical courier collection across more than 200 UK hospitals and home births, dual-location cryogenic storage, and complementary Non-Invasive Prenatal Testing (NIPT).
Product overview
Cells4Life offers a comprehensive suite of umbilical cord blood, cord tissue, and placenta stem cell banking services for families. The core offering is cord blood banking, available in two tiers: the standard Cells service using the NHS-trusted AXP processing system, and the premium Cells*Plus* service powered by proprietary TotiCyte technology that retains up to 2.2X more viable stem cells. As the UK's only placenta storage bank, Cells4Life also offers Amnion and Placental Cell banking as exclusive services. Additional offerings include cord tissue banking, prenatal testing (NIPT), and multiple sample storage options. All services include collection kit provision, 24/7 courier pickup, dual storage locations, and accredited processing and storage facilities.
Differentiator
Problem solved
Functional benefit
Brands
- Cells*Plus*: Proprietary stem cell processing technology that retains up to 2.2X more viable cells than standard processing methods, powered by TotiCyte technology.
- TotiCyte
- Placenta Banking
Products and services
- Cells (Standard) Cord Blood Banking Standard subscription-based umbilical cord blood stem cell banking service for expectant parents, using the AXP processing system to deliver 87% post-processing yield and 42% post-thaw yield. Includes 24/7 medical courier collection, dual-location storage, and long-term cryogenic preservation. Customers pay an upfront processing fee plus an annual storage subscription.
- Cells*Plus* (Premium) Cord Blood Banking Premium subscription-based cord blood stem cell banking service powered by proprietary TotiCyte technology, retaining up to 2.2X more viable haematopoietic stem cells than the standard Cells service. Achieves 90% post-processing yield and 66% post-thaw yield, with 99% waste red cell removal. Targeted at expectant parents who want to maximise the therapeutic potential of the stored sample.
- Cord Tissue Banking Subscription-based service for the collection, processing, and long-term storage of mesenchymal stem cells (MSCs) derived from the umbilical cord tissue, used for potential regenerative medicine applications. Sold as a standalone or add-on to cord blood banking packages for expectant parents.
- Placenta Banking Subscription-based service for the collection, processing, and long-term storage of placenta-derived stem cells (Amnion and Placental Cells), which have powerful regenerative properties. Exclusive to Cells4Life in the UK; sold as a premium add-on to cord blood and/or cord tissue banking packages.
- Amnion Banking Subscription-based service for the collection, processing, and long-term storage of amnion placental tissue, which contains powerful regenerative cells. Part of the broader placenta banking offering.
- Non-Invasive Prenatal Testing (NIPT) Professional non-invasive prenatal testing (NIPT) service offered to expectant parents, providing prenatal screening for chromosomal and genetic conditions. Marketed as a complementary add-on to Cells4Life's stem cell banking services.
Quantifiable outcome
- Up to 2.2X more viable haematopoietic stem cells at point of use with Cells*Plus* (TotiCyte) compared to next-best AXP system
- +4 more outcomes
Companies that use Cells4Life
Customer profileNamed customers7 records
Segments3 records
Ideal customer profiles2 records
Cells4Life technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Cells4Life partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- National Health Service (NHS)coreCells4Life uses the AXP (AutoXpresser Platform) processing system, which is the same technology exclusively used by the NHS for cord blood processing. This shared technology platform establishes a technical alignment and implicit endorsement between Cells4Life and the NHS, positioning Cells4Life's standard service at the same quality level as the UK's public healthcare system.
Scale indicators8 records
Recent moves6 records
Expansion highlights5 records
Cells4Life competitors and assessment
Company assessmentDirect peers
- Smart Cells International: UK-based private cord blood banking service offering collection, processing, and long-term cryogenic storage of umbilical cord blood and cord tissue. Directly competes with Cells4Life in the UK family banking segment with overlapping product tiers and hospital collection partnerships.
- Future Health Biobank: UK-based stem cell bank storing cord blood, cord tissue, and dental pulp stem cells for family use. Operates internationally across UK, Europe, Middle East, and Asia - a direct competitor to Cells4Life with similar service offerings and pricing model.
- Biovault Family: UK private cord blood and tissue bank offering family banking services with HTA licensing. Directly competes with Cells4Life in the UK private banking segment with similar regulatory credentials and target customer base of expectant parents.
- Cryo-Cell International: US-headquartered global cord blood banking service operating for over 30 years with public market listing. Comparable business model of family cord blood banking with international presence and accreditation-driven positioning.
- ViaCord: US private cord blood and cord tissue banking service with multi-decade operating history, currently part of Revvity (formerly PerkinElmer). Directly comparable family banking model with proprietary processing technology and hospital collection network.
- Precious Cells International: UK-based stem cell banking service offering cord blood, cord tissue, and placental cell storage. Direct competitor to Cells4Life in UK family banking segment with similar regulatory positioning and target customers.
Broad incumbents
- CBR (Cord Blood Registry): One of the largest US private cord blood banks, now part of CooperCompanies. Comparable family banking proposition at significantly larger scale, demonstrating the upper-bound of private cord blood banking market potential.
- StemCyte: Global cord blood bank operating both public and private banking across US, Taiwan, and India. Comparable dual public/private banking infrastructure with international scope overlapping Cells4Life's UK and Middle East exposure.
Regional players
- Insception Lifebank: Canada's largest private cord blood bank, offering family cord blood and tissue banking comparable to Cells4Life. Comparable business model and regulatory positioning in a different geography, useful as a regional benchmark for international expansion.
- Esperite NV (Cryo-Save): Europe-headquartered stem cell banking group historically operating across multiple countries including UK. Comparable family cord blood and tissue banking services in European geographies overlapping with Cells4Life's stated European customer reach.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Cells4Life social profiles
Digital presenceCells4Life compliance and trust
Trust signalCompliance6 records
Cells4Life financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cells4Life leadership team
Management profileNumber of profiles
Profiles2 records
Cells4Life funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cells4Life M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cells4Life
What does Cells4Life do?
Cells4Life collects, processes, tests, and cryogenically stores umbilical cord blood, cord tissue, placenta, and amnion-derived stem cells for expectant parents and families, offering both a standard Cells service (using the AXP system trusted by the NHS) and a premium Cells*Plus* service powered by proprietary TotiCyte technology that retains up to 2.2X more viable stem cells. Services include 24/7 medical courier collection across more than 200 UK hospitals and home births, dual-location cryogenic storage, and complementary Non-Invasive Prenatal Testing (NIPT).
Is Cells4Life a public or private company?
Cells4Life is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Cells4Life founded?
Cells4Life was founded in 2002. It employs 11 to 50 people.
Where is Cells4Life based?
Cells4Life is headquartered in Burgess Hill, United Kingdom, in the Europe region.
How does Cells4Life make money?
Six revenue lines are on record. Cord Blood Banking - Cells (Standard Service) is the primary driver. The others are cord Blood Banking - Cells*Plus* (Premium Service), cord Tissue Banking, placenta Banking (Exclusive UK Service), amnion Banking and prenatal Testing (NIPT).
Who are Cells4Life's main competitors?
Direct peers on record are Smart Cells International, Future Health Biobank, Biovault Family, Cryo-Cell International, ViaCord and Precious Cells International. Broad incumbents are CBR (Cord Blood Registry) and StemCyte. Regional players are Insception Lifebank and Esperite NV (Cryo-Save).
Does Cells4Life have an API?
No public API is recorded for Cells4Life.
What industry is Cells4Life in?
Cells4Life's product category is Stem Cell Banking Services. Its primary akta.pro industry code is HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue), with a secondary code of HLAAAGAA, Stem Cell–Based Regenerative Therapies. Its NAICS code is 621991 and its SIC code is 8071.